nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1A1—Dacarbazine—muscle cancer	0.24	0.298	CbGbCtD
Flutamide—CYP1B1—Doxorubicin—muscle cancer	0.183	0.227	CbGbCtD
Flutamide—CYP1A2—Dacarbazine—muscle cancer	0.107	0.133	CbGbCtD
Flutamide—CYP3A5—Vincristine—muscle cancer	0.0771	0.0955	CbGbCtD
Flutamide—CYP3A5—Etoposide—muscle cancer	0.0706	0.0875	CbGbCtD
Flutamide—CYP1A2—Etoposide—muscle cancer	0.0526	0.0651	CbGbCtD
Flutamide—CYP3A4—Vincristine—muscle cancer	0.03	0.0372	CbGbCtD
Flutamide—CYP3A4—Etoposide—muscle cancer	0.0275	0.0341	CbGbCtD
Flutamide—AR—scrotum—muscle cancer	0.0207	0.347	CbGeAlD
Flutamide—CYP3A4—Doxorubicin—muscle cancer	0.0188	0.0233	CbGbCtD
Flutamide—Proctitis—Dactinomycin—muscle cancer	0.00871	0.0655	CcSEcCtD
Flutamide—Necrolysis epidermal—Etoposide—muscle cancer	0.00678	0.051	CcSEcCtD
Flutamide—Metastatic neoplasm—Doxorubicin—muscle cancer	0.00416	0.0313	CcSEcCtD
Flutamide—Necrolysis epidermal—Methotrexate—muscle cancer	0.00406	0.0305	CcSEcCtD
Flutamide—Proctitis—Doxorubicin—muscle cancer	0.00327	0.0246	CcSEcCtD
Flutamide—AHR—smooth muscle tissue—muscle cancer	0.00321	0.0537	CbGeAlD
Flutamide—Nodule—Methotrexate—muscle cancer	0.00314	0.0236	CcSEcCtD
Flutamide—AHR—cardiac atrium—muscle cancer	0.00276	0.0463	CbGeAlD
Flutamide—AHR—tendon—muscle cancer	0.00241	0.0403	CbGeAlD
Flutamide—AHR—bone marrow—muscle cancer	0.00233	0.0391	CbGeAlD
Flutamide—Ulcer—Dactinomycin—muscle cancer	0.00225	0.0169	CcSEcCtD
Flutamide—AHR—vagina—muscle cancer	0.00224	0.0374	CbGeAlD
Flutamide—Interstitial lung disease—Etoposide—muscle cancer	0.00217	0.0163	CcSEcCtD
Flutamide—Bullous eruption—Doxorubicin—muscle cancer	0.00202	0.0152	CcSEcCtD
Flutamide—Loss of libido—Methotrexate—muscle cancer	0.002	0.015	CcSEcCtD
Flutamide—AHR—testis—muscle cancer	0.00199	0.0334	CbGeAlD
Flutamide—Laboratory test abnormal—Doxorubicin—muscle cancer	0.00191	0.0144	CcSEcCtD
Flutamide—CYP1B1—smooth muscle tissue—muscle cancer	0.00167	0.028	CbGeAlD
Flutamide—Ulcer—Etoposide—muscle cancer	0.00163	0.0122	CcSEcCtD
Flutamide—CYP1B1—renal system—muscle cancer	0.00161	0.0269	CbGeAlD
Flutamide—AR—smooth muscle tissue—muscle cancer	0.00158	0.0265	CbGeAlD
Flutamide—AR—renal system—muscle cancer	0.00152	0.0255	CbGeAlD
Flutamide—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.00139	0.0105	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00139	0.0105	CcSEcCtD
Flutamide—AR—cardiac atrium—muscle cancer	0.00136	0.0228	CbGeAlD
Flutamide—Transaminases increased—Doxorubicin—muscle cancer	0.00131	0.00987	CcSEcCtD
Flutamide—Interstitial lung disease—Methotrexate—muscle cancer	0.0013	0.00979	CcSEcCtD
Flutamide—CYP1B1—tendon—muscle cancer	0.00125	0.021	CbGeAlD
Flutamide—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00124	0.00934	CcSEcCtD
Flutamide—Herpes zoster—Methotrexate—muscle cancer	0.00122	0.0092	CcSEcCtD
Flutamide—AR—tendon—muscle cancer	0.00119	0.0199	CbGeAlD
Flutamide—CYP1A2—renal system—muscle cancer	0.00115	0.0193	CbGeAlD
Flutamide—CYP1A1—renal system—muscle cancer	0.00114	0.019	CbGeAlD
Flutamide—CYP3A5—renal system—muscle cancer	0.00111	0.0186	CbGeAlD
Flutamide—AR—vagina—muscle cancer	0.0011	0.0185	CbGeAlD
Flutamide—Erectile dysfunction—Vincristine—muscle cancer	0.0011	0.00825	CcSEcCtD
Flutamide—Photosensitivity reaction—Vincristine—muscle cancer	0.00109	0.00818	CcSEcCtD
Flutamide—CYP1B1—head—muscle cancer	0.00108	0.018	CbGeAlD
Flutamide—Hepatitis—Dactinomycin—muscle cancer	0.00107	0.00803	CcSEcCtD
Flutamide—Herpes zoster—Doxorubicin—muscle cancer	0.00106	0.00797	CcSEcCtD
Flutamide—CYP1B1—testis—muscle cancer	0.00104	0.0174	CbGeAlD
Flutamide—CYP2C19—vagina—muscle cancer	0.00102	0.0171	CbGeAlD
Flutamide—AR—head—muscle cancer	0.00102	0.0171	CbGeAlD
Flutamide—CYP1A1—cardiac atrium—muscle cancer	0.00102	0.017	CbGeAlD
Flutamide—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00101	0.00756	CcSEcCtD
Flutamide—AR—testis—muscle cancer	0.000984	0.0165	CbGeAlD
Flutamide—Ulcer—Methotrexate—muscle cancer	0.000975	0.00733	CcSEcCtD
Flutamide—Liver injury—Doxorubicin—muscle cancer	0.000949	0.00713	CcSEcCtD
Flutamide—Neoplasm malignant—Doxorubicin—muscle cancer	0.000935	0.00703	CcSEcCtD
Flutamide—Erythema—Dactinomycin—muscle cancer	0.00093	0.00699	CcSEcCtD
Flutamide—Pulmonary embolism—Methotrexate—muscle cancer	0.000922	0.00693	CcSEcCtD
Flutamide—Jaundice cholestatic—Doxorubicin—muscle cancer	0.000909	0.00683	CcSEcCtD
Flutamide—Cystitis noninfective—Methotrexate—muscle cancer	0.000901	0.00677	CcSEcCtD
Flutamide—Cystitis—Methotrexate—muscle cancer	0.00089	0.00669	CcSEcCtD
Flutamide—Rectal haemorrhage—Doxorubicin—muscle cancer	0.000884	0.00664	CcSEcCtD
Flutamide—Ill-defined disorder—Dactinomycin—muscle cancer	0.000863	0.00649	CcSEcCtD
Flutamide—Anaemia—Dactinomycin—muscle cancer	0.000859	0.00646	CcSEcCtD
Flutamide—Ulcer—Doxorubicin—muscle cancer	0.000844	0.00635	CcSEcCtD
Flutamide—Jaundice—Etoposide—muscle cancer	0.000839	0.00631	CcSEcCtD
Flutamide—Malaise—Dactinomycin—muscle cancer	0.000838	0.0063	CcSEcCtD
Flutamide—CYP3A4—renal system—muscle cancer	0.000834	0.014	CbGeAlD
Flutamide—Neoplasm—Methotrexate—muscle cancer	0.000834	0.00627	CcSEcCtD
Flutamide—Ecchymosis—Methotrexate—muscle cancer	0.000834	0.00627	CcSEcCtD
Flutamide—Bladder pain—Methotrexate—muscle cancer	0.000834	0.00627	CcSEcCtD
Flutamide—Leukopenia—Dactinomycin—muscle cancer	0.000832	0.00626	CcSEcCtD
Flutamide—Gynaecomastia—Methotrexate—muscle cancer	0.000825	0.0062	CcSEcCtD
Flutamide—CYP1A1—vagina—muscle cancer	0.000823	0.0138	CbGeAlD
Flutamide—CYP3A5—vagina—muscle cancer	0.000805	0.0135	CbGeAlD
Flutamide—Pulmonary embolism—Doxorubicin—muscle cancer	0.000798	0.006	CcSEcCtD
Flutamide—Discomfort—Dactinomycin—muscle cancer	0.000782	0.00588	CcSEcCtD
Flutamide—Cystitis noninfective—Doxorubicin—muscle cancer	0.00078	0.00586	CcSEcCtD
Flutamide—Cystitis—Doxorubicin—muscle cancer	0.000771	0.0058	CcSEcCtD
Flutamide—Diabetes mellitus—Methotrexate—muscle cancer	0.000769	0.00578	CcSEcCtD
Flutamide—Anaemia—Vincristine—muscle cancer	0.000768	0.00577	CcSEcCtD
Flutamide—CYP1A1—head—muscle cancer	0.00076	0.0127	CbGeAlD
Flutamide—Oedema—Dactinomycin—muscle cancer	0.000759	0.0057	CcSEcCtD
Flutamide—Blood urea increased—Doxorubicin—muscle cancer	0.000754	0.00567	CcSEcCtD
Flutamide—Leukopenia—Vincristine—muscle cancer	0.000744	0.00559	CcSEcCtD
Flutamide—Thrombocytopenia—Dactinomycin—muscle cancer	0.000743	0.00559	CcSEcCtD
Flutamide—Anorexia—Dactinomycin—muscle cancer	0.000723	0.00544	CcSEcCtD
Flutamide—Ecchymosis—Doxorubicin—muscle cancer	0.000722	0.00543	CcSEcCtD
Flutamide—Bladder pain—Doxorubicin—muscle cancer	0.000722	0.00543	CcSEcCtD
Flutamide—Neoplasm—Doxorubicin—muscle cancer	0.000722	0.00543	CcSEcCtD
Flutamide—Hypertension—Vincristine—muscle cancer	0.000717	0.00539	CcSEcCtD
Flutamide—Oedema—Vincristine—muscle cancer	0.000678	0.0051	CcSEcCtD
Flutamide—Diabetes mellitus—Doxorubicin—muscle cancer	0.000666	0.00501	CcSEcCtD
Flutamide—Thrombocytopenia—Vincristine—muscle cancer	0.000664	0.00499	CcSEcCtD
Flutamide—Decreased appetite—Dactinomycin—muscle cancer	0.00066	0.00496	CcSEcCtD
Flutamide—Fatigue—Dactinomycin—muscle cancer	0.000654	0.00492	CcSEcCtD
Flutamide—Anorexia—Vincristine—muscle cancer	0.000646	0.00486	CcSEcCtD
Flutamide—Feeling abnormal—Dactinomycin—muscle cancer	0.000625	0.0047	CcSEcCtD
Flutamide—Ill-defined disorder—Etoposide—muscle cancer	0.000624	0.00469	CcSEcCtD
Flutamide—Anaemia—Etoposide—muscle cancer	0.000622	0.00468	CcSEcCtD
Flutamide—Hot flush—Doxorubicin—muscle cancer	0.000619	0.00466	CcSEcCtD
Flutamide—Increased appetite—Doxorubicin—muscle cancer	0.000617	0.00464	CcSEcCtD
Flutamide—Menopausal symptoms—Doxorubicin—muscle cancer	0.000614	0.00462	CcSEcCtD
Flutamide—Insomnia—Vincristine—muscle cancer	0.000613	0.00461	CcSEcCtD
Flutamide—Malaise—Etoposide—muscle cancer	0.000607	0.00456	CcSEcCtD
Flutamide—Dermatitis bullous—Doxorubicin—muscle cancer	0.000606	0.00456	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000603	0.00453	CcSEcCtD
Flutamide—Leukopenia—Etoposide—muscle cancer	0.000602	0.00453	CcSEcCtD
Flutamide—Decreased appetite—Vincristine—muscle cancer	0.000589	0.00443	CcSEcCtD
Flutamide—Fatigue—Vincristine—muscle cancer	0.000584	0.00439	CcSEcCtD
Flutamide—Hypertension—Etoposide—muscle cancer	0.000581	0.00437	CcSEcCtD
Flutamide—Constipation—Vincristine—muscle cancer	0.00058	0.00436	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000569	0.00428	CcSEcCtD
Flutamide—Discomfort—Etoposide—muscle cancer	0.000566	0.00426	CcSEcCtD
Flutamide—Confusional state—Etoposide—muscle cancer	0.000554	0.00416	CcSEcCtD
Flutamide—Asthenia—Dactinomycin—muscle cancer	0.000544	0.00409	CcSEcCtD
Flutamide—Thrombocytopenia—Etoposide—muscle cancer	0.000538	0.00404	CcSEcCtD
Flutamide—Skin disorder—Etoposide—muscle cancer	0.000533	0.00401	CcSEcCtD
Flutamide—Erectile dysfunction—Methotrexate—muscle cancer	0.000533	0.00401	CcSEcCtD
Flutamide—Photosensitivity reaction—Methotrexate—muscle cancer	0.000528	0.00397	CcSEcCtD
Flutamide—Anorexia—Etoposide—muscle cancer	0.000523	0.00394	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000522	0.00392	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000522	0.00392	CcSEcCtD
Flutamide—Diarrhoea—Dactinomycin—muscle cancer	0.000519	0.0039	CcSEcCtD
Flutamide—Drowsiness—Methotrexate—muscle cancer	0.000516	0.00388	CcSEcCtD
Flutamide—Haematuria—Methotrexate—muscle cancer	0.000492	0.0037	CcSEcCtD
Flutamide—Somnolence—Etoposide—muscle cancer	0.000488	0.00367	CcSEcCtD
Flutamide—Asthenia—Vincristine—muscle cancer	0.000486	0.00366	CcSEcCtD
Flutamide—Vomiting—Dactinomycin—muscle cancer	0.000482	0.00363	CcSEcCtD
Flutamide—Rash—Dactinomycin—muscle cancer	0.000478	0.0036	CcSEcCtD
Flutamide—Decreased appetite—Etoposide—muscle cancer	0.000477	0.00359	CcSEcCtD
Flutamide—Fatigue—Etoposide—muscle cancer	0.000473	0.00356	CcSEcCtD
Flutamide—Constipation—Etoposide—muscle cancer	0.00047	0.00353	CcSEcCtD
Flutamide—Diarrhoea—Vincristine—muscle cancer	0.000464	0.00349	CcSEcCtD
Flutamide—Hepatitis—Methotrexate—muscle cancer	0.000463	0.00348	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000457	0.00344	CcSEcCtD
Flutamide—Feeling abnormal—Etoposide—muscle cancer	0.000453	0.0034	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—muscle cancer	0.000452	0.0034	CcSEcCtD
Flutamide—Nausea—Dactinomycin—muscle cancer	0.000451	0.00339	CcSEcCtD
Flutamide—Dizziness—Vincristine—muscle cancer	0.000448	0.00337	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—muscle cancer	0.000447	0.00336	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—muscle cancer	0.000435	0.00327	CcSEcCtD
Flutamide—Vomiting—Vincristine—muscle cancer	0.000431	0.00324	CcSEcCtD
Flutamide—Rash—Vincristine—muscle cancer	0.000427	0.00321	CcSEcCtD
Flutamide—Dermatitis—Vincristine—muscle cancer	0.000427	0.00321	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—muscle cancer	0.000426	0.0032	CcSEcCtD
Flutamide—Headache—Vincristine—muscle cancer	0.000425	0.00319	CcSEcCtD
Flutamide—Erythema—Methotrexate—muscle cancer	0.000403	0.00303	CcSEcCtD
Flutamide—Nausea—Vincristine—muscle cancer	0.000403	0.00303	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—muscle cancer	0.000401	0.00301	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—muscle cancer	0.000395	0.00297	CcSEcCtD
Flutamide—Asthenia—Etoposide—muscle cancer	0.000394	0.00296	CcSEcCtD
Flutamide—Pruritus—Etoposide—muscle cancer	0.000389	0.00292	CcSEcCtD
Flutamide—Diarrhoea—Etoposide—muscle cancer	0.000376	0.00282	CcSEcCtD
Flutamide—Ill-defined disorder—Methotrexate—muscle cancer	0.000374	0.00281	CcSEcCtD
Flutamide—Anaemia—Methotrexate—muscle cancer	0.000373	0.0028	CcSEcCtD
Flutamide—Malaise—Methotrexate—muscle cancer	0.000363	0.00273	CcSEcCtD
Flutamide—Dizziness—Etoposide—muscle cancer	0.000363	0.00273	CcSEcCtD
Flutamide—Leukopenia—Methotrexate—muscle cancer	0.000361	0.00271	CcSEcCtD
Flutamide—Vomiting—Etoposide—muscle cancer	0.000349	0.00262	CcSEcCtD
Flutamide—Erythema—Doxorubicin—muscle cancer	0.000349	0.00262	CcSEcCtD
Flutamide—Rash—Etoposide—muscle cancer	0.000346	0.0026	CcSEcCtD
Flutamide—Dermatitis—Etoposide—muscle cancer	0.000346	0.0026	CcSEcCtD
Flutamide—Headache—Etoposide—muscle cancer	0.000344	0.00259	CcSEcCtD
Flutamide—Tension—Doxorubicin—muscle cancer	0.000342	0.00257	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000341	0.00256	CcSEcCtD
Flutamide—Discomfort—Methotrexate—muscle cancer	0.000339	0.00255	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—muscle cancer	0.000339	0.00255	CcSEcCtD
Flutamide—Confusional state—Methotrexate—muscle cancer	0.000332	0.00249	CcSEcCtD
Flutamide—Nausea—Etoposide—muscle cancer	0.000326	0.00245	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—muscle cancer	0.000324	0.00243	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—muscle cancer	0.000323	0.00243	CcSEcCtD
Flutamide—Thrombocytopenia—Methotrexate—muscle cancer	0.000322	0.00242	CcSEcCtD
Flutamide—Skin disorder—Methotrexate—muscle cancer	0.00032	0.0024	CcSEcCtD
Flutamide—Malaise—Doxorubicin—muscle cancer	0.000315	0.00237	CcSEcCtD
Flutamide—Anorexia—Methotrexate—muscle cancer	0.000314	0.00236	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—muscle cancer	0.000312	0.00235	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—muscle cancer	0.000301	0.00227	CcSEcCtD
Flutamide—Insomnia—Methotrexate—muscle cancer	0.000298	0.00224	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—muscle cancer	0.000296	0.00223	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000295	0.00222	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—muscle cancer	0.000294	0.00221	CcSEcCtD
Flutamide—Somnolence—Methotrexate—muscle cancer	0.000292	0.0022	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—muscle cancer	0.000287	0.00216	CcSEcCtD
Flutamide—Decreased appetite—Methotrexate—muscle cancer	0.000286	0.00215	CcSEcCtD
Flutamide—Oedema—Doxorubicin—muscle cancer	0.000285	0.00214	CcSEcCtD
Flutamide—Fatigue—Methotrexate—muscle cancer	0.000284	0.00213	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—muscle cancer	0.000279	0.0021	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—muscle cancer	0.000277	0.00208	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—muscle cancer	0.000272	0.00204	CcSEcCtD
Flutamide—Feeling abnormal—Methotrexate—muscle cancer	0.000271	0.00204	CcSEcCtD
Flutamide—Insomnia—Doxorubicin—muscle cancer	0.000258	0.00194	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—muscle cancer	0.000253	0.0019	CcSEcCtD
Flutamide—Decreased appetite—Doxorubicin—muscle cancer	0.000248	0.00186	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—muscle cancer	0.000246	0.00185	CcSEcCtD
Flutamide—Constipation—Doxorubicin—muscle cancer	0.000244	0.00183	CcSEcCtD
Flutamide—Asthenia—Methotrexate—muscle cancer	0.000236	0.00177	CcSEcCtD
Flutamide—Feeling abnormal—Doxorubicin—muscle cancer	0.000235	0.00176	CcSEcCtD
Flutamide—Pruritus—Methotrexate—muscle cancer	0.000233	0.00175	CcSEcCtD
Flutamide—Diarrhoea—Methotrexate—muscle cancer	0.000225	0.00169	CcSEcCtD
Flutamide—Dizziness—Methotrexate—muscle cancer	0.000218	0.00164	CcSEcCtD
Flutamide—Vomiting—Methotrexate—muscle cancer	0.000209	0.00157	CcSEcCtD
Flutamide—Rash—Methotrexate—muscle cancer	0.000207	0.00156	CcSEcCtD
Flutamide—Dermatitis—Methotrexate—muscle cancer	0.000207	0.00156	CcSEcCtD
Flutamide—Headache—Methotrexate—muscle cancer	0.000206	0.00155	CcSEcCtD
Flutamide—Asthenia—Doxorubicin—muscle cancer	0.000204	0.00154	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—muscle cancer	0.000202	0.00151	CcSEcCtD
Flutamide—Nausea—Methotrexate—muscle cancer	0.000195	0.00147	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—muscle cancer	0.000195	0.00147	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—muscle cancer	0.000188	0.00142	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—muscle cancer	0.000181	0.00136	CcSEcCtD
Flutamide—Rash—Doxorubicin—muscle cancer	0.00018	0.00135	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—muscle cancer	0.000179	0.00135	CcSEcCtD
Flutamide—Headache—Doxorubicin—muscle cancer	0.000178	0.00134	CcSEcCtD
Flutamide—Nausea—Doxorubicin—muscle cancer	0.000169	0.00127	CcSEcCtD
